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ABSTRACT
In order to estimate the current coverage rate among all children in Greenland, we conducted an
observational cross-sectional study identifying all children in Greenland eligible for a vaccination
between 1March 2018 and 16 June 2019. we found an overall national coverage of 85.4%. The national
coverage for the vaccinations given at birthwas 97.1%, dropping to 94.3%, 87.7% and 83.6% at ages 3, 5
and 12months. Among children eligible for theMeasles, Mumps and Rubella-vaccinations, the national
coverage was 76.9% for children aged 15months and 64.1% for children aged 4 years, but dropping to
40.9% in the districts. At preschool, the national coverage was 79.9%. Among the 12-year-old, the
national coverages of the two vaccinations against Human Papilloma Virus were 88.4% and 71.6%,
respectively, and for the three Hepatitis B-vaccinations 89.8%, 84.1% and 69.6%. A subgroup-analysis
and test of an SMS-reminder system in Nuuk improved the coverage from 57.8% to 75.5% locally.
Overall, we found a high national coverage rate among the newborn in Greenland. The national
coverage rates of the remaining vaccinations were below the WHO-recommendations, however with
great regional differences.
Abbreviations: CVP: Children Vaccination Programme; BCG: Bacille Calmette–Guerin; EMR:
Electronic medical Record system; DTPHiB: Diphtheria, Tetanus, Pertussis, Polio, Haemophilus
influenza B; HBV: Hepatitis B; HPV: Human Papilloma Virus; MMR: Measles, Mumps, Rubella;
SMS: Short Text Message; WHO: World Health Organization; GVAP: Global Vaccine Action Plan;
EVAP: The WHO European Vaccine Action Plan.
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In the previous years, Europe has seen 160,000 cases of
measles and over 100 deaths related to this highly infectious
disease [1]. This includes outbreaks of measles in places close
toGreenland, such as Denmark and the Inuit-area of Inuvik in
Northern America [2,3].
The vaccination against measles is included in the
Children Vaccination Programme (CVP) throughout Europe,
including Greenland. According to the World Health
Organisation (WHO), a vaccination coverage rate of at least
95% is needed in order to prevent outbreaks and eliminate
this disease [1].
Recently, studies of coverage rates among children in
two larger towns in Greenland, Nuuk, the capital and
Ilulissat, the third-largest town, have revealed suboptimal
vaccination rates among children. In 2016, a study of the
vaccination rates among children in Nuuk wasmade based
on data extraction from a new electronic medical record
system (EMR), which was introduced in March 2015 and
includes a registration module for vaccinations. This study
showed relatively high vaccination rates among children
younger than 12months (80–99%), but rates as low as 55%
and 34% for the first and second vaccination against
measles, mumps and rubella (MMR) among preschool-
children [4]. Another study from 2016 found that in the
towns of Nuuk and Ilulissat, the total adherence to the
vaccination programme among children up to the age of
10 years was 40%. Fifty-five per cent had incomplete adher-
ence and 5% did not follow the programme at all [5].
However, the current coverage rate of the CVP among
children in all of Greenland is unknown. A former study
performed in 2004 based on the number of vaccinations
reported to the chief medical officer compared to the
number of children in Greenland estimated “reasonably
well coverage” among children younger than 2 years, but
with variation among the healthcare districts in Greenland
[6]. Another study from 2003 reported high coverage rates
among children younger than 2 years in the town Sisimiut
but dropping rates among the older children [7].
The EMR introduced in Nuuk in 2015 was implemen-
ted in all hospitals and healthcare centres in Greenland
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between November 2016 and July 2017, except the
town Taasilaq in east Greenland. This makes it possible
to estimate the national coverage rates based on data-
extraction. This is highly relevant in order to prevent
the spreading of preventable infectious diseases among
children in general and among adults and children with
immune-diseases.
Thus, the objective of this study was to estimate the
current vaccination rates among children in all of
Greenland.
Materials and method
The study was designed as an observational cross-
sectional study based on statistical extractions and
review of medical records.
Setting
Greenland is the largest island in the world covering
approximately two million square kilometres. It is spar-
sely populated with a total of 56,000 inhabitants living
in 17 towns and approximately 60 minor settlements.
Twenty-four per cent of the population is children aged
16 years or younger [8]. The widespread population
represents a real challenge to the national healthcare
system in order to deliver high-quality healthcare, such
as the CVP, to all inhabitants.
The healthcare system is divided into five healthcare
regions: Avannaa, Disko, Qeqqa, Sermersooq and Kujataa
(Figure 1). Each region consists of a number of towns and
settlements. A regional healthcare centre is located in the
largest town of the region while smaller local clinics exist in
all other towns. Healthcare stations in settlements are the
smallest healthcare units in Greenland [9].
The healthcare system in Greenland is a publicly
financed healthcare system, meaning that preventive
care, such as the vaccinations in the CVP, examinations
and treatment are free for anyone with a permanent
address in Greenland [10].
The CVP is based on the Danish programme with the
addition of the Bacille Calmette–Guerin (BCG)-
vaccination against tuberculosis and the vaccination-
programme against Hepatitis B (HBV). The latter was
introduced in 2010 and, as the first vaccination in this
programme is administered at birth, children born
before 2010 are offered three catch-up vaccinations
when they are in a school-class corresponding to the
age of 12 years [11–13].
The full programme and names and abbreviations of
the diseases the vaccinations protect against can be
found in Table 1.
A midwife administers the BCG- and HBV-
vaccinations given at birth, except when the child is
premature. Afterwards, the development and health of
the child are monitored by a nurse, a doctor or the local
health-worker until the child is approximately 12
months old. The health professional can remind and
inform the parents of the vaccinations at ages 3, 5
and 12 months. When the child enters school, the
vaccinations are offered to all children in specific school
years. Currently, Greenland has no reminder-system for
the vaccinations [13].
Study population
A statistical extraction identifying all children in
Greenland eligible for a vaccination in the CVP between
1 March 2018 and 16 June 2019 was performed and
their vaccination status registered.
The cohorts of children eligible for each of the vac-
cinations given before the age of 2 years were designed
to include all vaccinations registered in the EMR-
system unless the vaccination had been given with
more than 1-month delay among the youngest in the
cohorts.
The cohort of children eligible for the vaccination given
at the age of 4 years was designed to include all vaccina-
tions registered in the EMR unless the vaccination had
been given with more than 4 months’s delay.
For the vaccinations given at preschool and in
schools at specific school years (children aged 5 to 6
years and 12 years), the cohorts were designed to
include all children born in the year corresponding to
the specific school year.
One month after the initial data extraction,
a subgroup of children from Nuuk eligible for the first
MMR-vaccination was reviewed manually. Short text
messages (SMS) were sent to the parents of children
appearing to have missed the vaccine, reminding them
about the vaccine and informing them of the opening
hours of the Queen Ingrid Health Care Center in Nuuk,
where the vaccines in the CVP are administered. After 4
weeks, this group was reviewed again to assess the
success of the SMS-reminder.
The ages of the children in each cohort can be seen
in Table 1.
Data validation
The national EMR is directly linked to the national civil
registry (CPR) in Greenland, meaning that every person
with a permanent address in Greenland is automatically
registered in the EMR. Synchronisation of data between
the two systems is controlled by a built-in lookup function
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in the EMR to ensure that any recent changes to personal
information are imported and stored correctly in the EMR.
The consistency between the CPR and the EMR is validated
every 24 h which is the maximum latency period for
changes to the patients’ personal information.
The extracted data was validated through manual
revision of the EMR. A sub-sample of the extracted
data for 500 individuals was compared to their
medical records to check for the degree of accor-
dance between the extracted data and the EMR,
including vaccination status, vaccination date, vacci-
nation type and current address. The data extracted
was found to be in complete accordance with
the EMR.
Figure 1. The five healthcare regions of Greenland [33].
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Statistics
Data was extracted from the EMR between 5 July and
8 July 2019.
Group proportions were reported with percentages
and compared using the Pearson Chi-Square test.
A P-value of less than 0.05 was considered significant.
Calculations were made in Microsoft Excel ®.
Ethics
The study was approved by the Ethics Committee for
Medical Research in Greenland (study-ID: KVUG
2019–08) and the Agency for Health and Prevention in
Greenland (29 May 2019).
The study was conducted in accordance with the
Helsinki II-declaration.
Results
Total coverage rates
Total coverage rates can be found in Table 2.
Data-extraction showed that a total of 12,394 vaccina-
tions should have been administered during the study
period. Of these, 10,584 vaccinations were given, corre-
sponding to an overall national coverage rate of 85.4%.
The lowest total coverage rate was found in
Sermersooq (79.6%, p < 0.001) when compared to
Greenland as a whole and the highest was found in
Disko (91.7%, p < 0.001).
Tuberculosis
The coverage rates of the BCG-vaccination can be
found in Table 3.
We found a national coverage rate of 97.1% for the
BCG-vaccination. The lowest coverage rate was found in
Qeqqa at 92.4% (p < 0.001) and the highest in Avannaa
at 99.1% (p < 0.05).
Hepatitis B
The national and regional coverage rates of the HBV-
vaccinations can be found in Table 4.
The national coverage rate of the HBV-vaccination
was highest at the time of birth (96.4%) with a drop to
94.4% at 3 months (p < 0.05) and further and significant
drops to 88.4% at 5 months and 83.9% at 12 months (p
< 0.001 and p < 0.01). Among the 12-year olds, the
coverage was 89.8% with a significant drop to 84.4% at
age 12 years and 2 months (p < 0.01) and to 69.6% at
age 12 years and 6 months (p < 0.001). Regionally, for
the vaccinations administered among the children born
after 2010, the lowest coverage rate, 74.3%, was
observed at 12 months in Sermersooq and the highest,
100%, at 3 months in Kujataa.
Diphtheria, Tetanus, Pertussis, Polio, Haemophilus
influenza B (DTPHiB)
The coverage rates of the DTPHiB-vaccine can be found
in Table 5.
Table 1. The Greenlandic child vaccination programme per 2019 and cohorts.
Recommended age at
vaccination Vaccination-type
Cohort born
between
Age per 16 June 2019
(months)
0 weeks (at birth) BCG: Tuberculosis
Hepatitis B (HBV)
01.03.18–15.05.19 1–15
3 months Pneumococcal, Diphteria, Tetanus, Whooping cough, Polio, Haemophilus
influenza B (DiTePerPoHiB), HBV
01.12.17–15.02.19 4–18
5 months Pneumococcal, DiTePerPolHiB, HBV 01.10.17–15.12.18 6–20
12 months Pneumococcal, DiTePerPolHiB, HBV 01.03.17–15.05.18 13–27
15 months Measles, Mumps, Rubella (MMR) 01.12.16–15.02.18 16–30
4 years MMR 01.03.14–15.02.15 52–63
5-6 years (preschool) DiTePerPolHiB 01.01.12–31.12.12 78–90
12 years + 0 months Human Papillomavirus (HPV) (girls only)
HBVa
01.01.06–31.12.06 150–162
12 years + 2 months HBV a 01.01.06–31.12.06 150–162
12 years + 6 months HPV, HBVa
Engerix-B-3
01.01.06–31.12.06 150–162
aChildren born before the vaccines administered at birth, 3 months, 5 months and 12 months were introduced, are offered three vaccinations when they are
in a school-class corresponding to the age of 12 years.
Table 2. Total coverage rates for all healthcare districts and
Greenland as a total.
Vaccinated Not vaccinated Total Coverage Rate %
Avannaa 2,412 346 2,758 87.5**
Disko 1,466 133 1,599 91.7***
Kujataa 1,289 158 1,447 89.1***
Qeqqa 1,955 287 2,242 87.2*
Sermersooq 3,462 886 4,348 79.6***
Greenland 10,584 1,810 12,394 85.4
Asterisk symbol : significant higher or lower coverage rate when compared
to Greenland as a whole.
*p < 0.05.
**p < 0.01.
***p < 0.001.
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The DTPHiB-vaccine is given in conjugation with the
HBV-vaccine at age 3, 5 and 12 months and so the
national and local coverages are the same as the HBV-
vaccine at these ages.
Regarding the booster given at preschool at age five
or 6 years, we found a national coverage of 79.9%.
Sermersooq and Qeqqa both had significantly lower
coverage rates when compared to the rest of
Greenland at 70.4% and 71.9%, respectively (p < 0.001
and p < 0.05), and Avannaa and Disko both had sig-
nificantly higher coverage rates at 93.5% and 92.7%
(both p < 0.001).
Pneumococcal disease
All coverage rates for the vaccine against pneumococ-
cal disease can be found in Table 3.
The national coverage of the vaccination against
pneumococcal disease was 94.3% at 3 months, 87.7%
at 5 months and 83.6% at 12 months. There were
significant drops in the coverage rate between each
vaccination (p < 0.001 and p < 0.05).
Regionally, the highest coverage rate was found in
Kujataa at 100% at 3 months, and the lowest in
Sermersooq at 74.6% at 12 months. Avannaa, Disko and
Sermersooq had significant drops in coverage from 3 to 5
months and Sermersooq from 5 to 12 months.
Measles, Mumps and Rubella
All coverage rates for the MMR-vaccination can be seen
in Table 3.
The national coverage of the first MMR-vaccination
administered at 15 months was found to be 76.9% with
a significant drop to 64.1% (p < 0.001) for the second
vaccination at 5 years.
The lowest coverage rate for both vaccinations
was found in Sermersooq at 56.8% and 40.9%, both
significantly lower when compared to the rest of
the country (both p < 0.001). The highest coverage
rate for the first vaccination was found in Disko
at 89.4% and for the second in Kujataa at 92.0%
(both p < 0.001 when compared to the rest of the
country).
Table 3. Coverage rates of BCG, MMR and vaccinations against HPV and pneumococcal disease.
Tuberculosis Pneumococcal disease MMR HPV
0 months BCG 3 months 5 months 12 months 15 months 4 years 12 years 0 months 12 years 6 months
Avannaa
Vaccinated 215 196 161 148 159 141 69 54
Not vaccinated 2 22 36 36 21 20 5 20
Total 217 218 197 161,841 180 161 74 74
Coverage Rate % 99.1^ 89.9^^ 81.7^^* 80.4 88.3^^^ 87.6^^^ 93.2 73.0**
Disko
Vaccinated 109 114 100 106 110 78 49 42
Not vaccinated 3 1 12 10 13 17 2 9
Total 112 115 112 116 123 95 61 51
Coverage Rate % 97.3 (ns) 99.1^ 89.3** 91.4^ 89.4^^^ 82.1^^^ 96.1 82.4*
Kujataa
Vaccinated 108 108 111 105 101 69 28 14
Not vaccinated 1 0 3 8 15 6 6 20
Total 109 108 114 113 116 75 34 34
Coverage Rate % 99.1 (ns) 100^^ 97.4^^^ 92.9^^ 87.1^^ 92.0^^^ 82.4 41.2^^^***
Qeqqa
Vaccinated 159 154 148 159 145 58 49 46
Not vaccinated 13 7 11 13 25 59 9 12
Total 172 161 159 172 170 117 58 58
Coverage Rate % 92.4^^^ 95.7 93.1^ 92.4^^^ 85.3^^ 49.6^^^*** 84.5 79.3*
Sermersooq
Vaccinated 319 277 257 241 176 104 116 96
Not vaccinated 8 21 47 82 134 150 19 39
Total 327 298 304 323 310 254 135 135
Coverage Rate % 97.6 (ns) 93.0 84.5^** 74.6^^^** 56.8^^^ 40.9^^^*** 85.9 71.1**
Greenland
Vaccinated 910 849 777 759 691 450 311 252
Not vaccinated 27 51 109 149 208 252 41 100
Total 937 900 886 908 899 702 352 352
Coverage Rate % 97.1 94.3 87.7*** 83.6* 76.9 64.1*** 88.4 71.6***
Asterisk symbol : significant decrease/increase in coverage rate when compared to previous vaccination in the same region.
*p < 0.05, ** p < 0.01, ***p < 0.001.
Cap symbol : significantly lower/higher coverage rate when compared to the rest of Greenland.
^: p < 0.05, ^^: p < 0.01, ^^^: p < 0.001.
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Sermersooq and Qeqqa both had significant drops in
the coverage rate between the two vaccinations.
Human Papillomavirus (HPV)
The coverage rates of the HPV-vaccination can be found
in Table 3.
We found the national coverage rate of the first HPV-
vaccination to be 88.4%, with a significant drop to
71.6% at the second vaccination (p < 0.001).
There were no significant differences between the
coverage rates of the first vaccination in any of the
regions when compared to the rest of the country,
but the coverage rate of the second vaccination was
significantly lower in Kujataa (41.2%, p < 0.001).
Subgroup analysis of children in Nuuk regarding
the first MMR-vaccination
A subgroup of 289 of children living in Nuuk eligible for
the first MMR-vaccination was identified after the initial
data-extraction. We found that in this group, 57.8% (167/
289) had received the vaccination according to schedule.
A manual review 1 month later revealed that 3.8% (11/
289) of the children had moved to Nuuk before the MMR-
vaccination should have been administered, leaving their
vaccination-status unknown and the true coverage rate
60.1% (167/278). Furthermore, additional 15 children had
received the vaccination in the 1-month period after the
first data-extraction, thereby increasing the vaccination
rate to 65.5% (182/278). Among the remaining 96 chil-
dren, an SMS was sent to the parents of 80 children with
available telephone numbers. A final review performed 4
weeks after the SMS was sent, revealed that another 28
children had been vaccinated, increasing the coverage
rate to 75.5% (210/278). Among children that had
received all vaccines except the MMR, 44% (22/50) were
vaccinated after the SMS-reminder compared to 20% (6/
30) of the children were missing at least one other of the
vaccines in the CVP.
Discussion
The overall national coverage rate of the CVP of
85.4% documented in this study is relatively high,
indicating a general good public support and
Table 4. Coverage rates of HBV-vaccination.
HBV
0 months 3 months 5 months 12 months 12 years 0 months 12 years 2 months 12 years 6 months
Avannaa
Vaccinated 211 196 163 151 150 138 116
Not vaccinated 6 22 34 33 11 23 45
Total 217 218 197 184 161 161 161
Coverage Rate % 97.2 89.9^^^** 82.7^^* 82.1 93.2** 85.7* 72.0**
Disko
Vaccinated 107 114 102 106 84 84 72
Not vaccinated 5 1 10 10 7 7 19
Total 112 115 112 116 91 91 91
Coverage Rate % 95.5 99.1 ^* 91.1** 91.4^ 92.3 92.3^ 79.1^*
Kujataa
Vaccinated 106 108 111 106 65 59 34
Not vaccinated 3 0 3 7 11 17 42
Total 109 108 114 113 76 76 76
Coverage Rate % 97.2 100.0^^ 97.4^^ 93.8^^ 85.5 77.6 44.7^^^***
Qeqqa
Vaccinated 160 154 148 159 116 109 104
Not vaccinated 12 7 11 13 14 21 26
Total 172 161 159 172 130 130 130
Coverage Rate % 93.0 95.7 93.1^ 92.4^^^ 89.2 83.8 80.0^
Sermersooq
Vaccinated 319 278 259 240 230 214 174
Not vaccinated 8 20 45 83 30 46 86
Total 327 298 304 323 260 260 260
Coverage Rate % 97.6 93.3* 85.2^** 74.3^^^*** 88.5*** 82.3* 66.9***
Greenland
Vaccinated 903 850 783 762 645 604 500
Not vaccinated 34 50 103 146 73 114 218
Total 937 900 886 908 718 718 718
Coverage Rate % 96.4 94.4* 88.4*** 83.9** 89.8*** 84.1** 69.6***
Asterisk symbol : significant decrease/increase in coverage rate when compared to previous vaccination in the same region.
*p < 0.05, ** p < 0.01, *** p < 0.001.
Cap symbol : significantly lower/higher coverage rate when compared to the rest of Greenland.
^: p < 0.05, ^^: p < 0.01, ^^^: p < 0.001.
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adherence to the programme. However, a goal of
atleast 90% coverage rate of all vaccines in the CVP,
as suggested by the WHO Global Vaccine Action Plan
2011–2020 (GVAP), has not been reached in
Greenland [14].
The highest coverage rates were observed for vaccina-
tions given at birth (97%), followed by vaccinations admi-
nistered among children at or below 12months (82–94%)
and among school children (70–93%). The lowest rates
were observed for the MMR-vaccinations at 15 months
and 4 years, 77% and 64%, respectively. Even lower rates,
below 60%, were observed in Sermersooq, indicating
a pronounced need for improvement here when com-
pared to the other regions.
The results for each of the vaccines in the Greenlandic
CVP are discussed below.
Tuberculosis
Greenland is a high-endemic area for tuberculosis and in
2015 the incidence was 145 cases per 100,000 inhabitants
[15]. The BCG-vaccine has been part of the children vac-
cination programme since 1955 but was temporarily dis-
continued from 1991 to 1996 [16]. The BCG-vaccine
protects against meningitis and disseminated tuberculo-
sis in children [17] and Michelsen et al. found in a study in
Greenland from 2014 that the vaccine also protects
against mycobacterium tuberculosis-infection and tuber-
culosis-disease among Greenlanders [16].
We found high coverage rates in all regions, indicat-
ing that the current system with the vaccine being
administered at birth is highly effective.
Hepatitis B
The screening of pregnant women for HBV was intro-
duced in Greenland in 1992 and the vaccine became
a part of the CVP in 2010. WHO recommends a national
coverage of the HBV-vaccine of at least 90% in coun-
tries where the disease is endemic, such as Greenland
[14]. In this study, we found that this goal was reached
at birth and at 3 months.
In a study by Rex et al. [18], they found the coverage
rates in 2012 to be 55% for the vaccine administered at
birth and 38.5% for the fourth vaccine. In our study, we
found that the national coverage rates have improved
and more than doubled at 12 months since 2012, which
could signify a gradual improvement since the imple-
mentation of the vaccine in the CVP.
According to the WHO, having all three vaccinations
is essential in order to achieve at least 20 years, and
possibly lifelong, immunity [19]. As HBV can cause liver
diseases such as cirrhosis and hepatocellular carcinoma,
a follow-up on the children in Greenland that have not
completed the programme seems essential.
Diphtheria, Tetanus, Pertussis, Polio, Haemophilus
influenza B
The WHO European Vaccine Action Plan (EVAP) aims
towards a national coverage rate of at least 95% of
three doses of a DTP-containing vaccine in 2020 in at
least 90% of the member-countries and at least 90%
coverage in at least 90% of the regions in all member-
countries [20].
Nationally, Greenland reached a national coverage
rate above 90% only at age 3 months. Locally, three
of the regions reached coverage rates above 90% for
the three first vaccinations, namely Disko, Kujataa and
Qeqqa, while only Disko reached a coverage rate above
90% for all four. The Sermersooq-region only achieved
a coverage of at least 90% this for the first vaccination
given at 3 months and Avannaa only for the booster.
Table 5. Coverage rates of DTPHiB-vaccinations.
Diphteria, Tetanus, Petussis, Polio, Haemophilus
Influenza B
3 months 5 months 12 months Preschool
Avannaa
Vaccinated 196 163 151 144
Not vaccinated 22 34 33 10
Total 218 197 184 154
Coverage Rate % 89.9^^^** 82.7^^* 82.1 93.5^^^**
Disko
Vaccinated 114 102 106 89
Not vaccinated 1 10 10 7
Total 115 112 116 96
Coverage Rate % 99.1^* 91.1** 91.4^ 92.7^^^
Kujataa
Vaccinated 108 111 106 56
Not vaccinated 0 3 7 16
Total 108 114 113 72
Coverage Rate % 100.0^^ 97.4^^ 93.8^^ 77.8**
Qeqqa
Vaccinated 154 148 159 87
Not vaccinated 7 11 13 34
Total 161 159 172 121
Coverage Rate % 95.7 93.1^ 92.4^^^ 71.9^***
Sermersooq
Vaccinated 278 259 240 162
Not vaccinated 20 45 83 68
Total 298 304 323 230
Coverage Rate % 93.3* 85.2^** 74.3^^^*** 70.4^^^
Greenland
Vaccinated 850 783 762 538
Not vaccinated 50 103 146 135
Total 900 886 908 673
Coverage Rate % 94.4* 88.4*** 83.9** 79.9*
Asterisk symbol : significant decrease/increase in coverage rate when com-
pared to previous vaccination in the same region.
*p < 0.05, ** p < 0.01, *** p < 0.001
Cap symbol : significantly lower/higher coverage rate when compared to
the rest of Greenland.
^: p < 0.05, ^^: p < 0.01, ^^^: p < 0.001.
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This means that only 60% of the Greenlandic regions
reached the WHO-recommended goal of a 90% cover-
age of three doses of a DTP-containing vaccine.
In 2016, the coverage rates in Nuuk for the DTP-
containing vaccines were 91.5% at 3 months, 80.2% at
5 months, 69.8% at 12 months and 68.3% for the boos-
ter [4]. The current coverage rates in Sermersooq of
93.3%, 85.2%, 74.3% and 70.4% could therefore indicate
an improvement.
Pneumococcal disease
The incidence of respiratory infections caused by pneu-
mococci is high among children in Greenland. In 2016
Kløvgaard et al. found that diseases of the respiratory
system and diseases of the ear were among the most
common causes of hospitalisation among children and
otitis media one of the most common causes for out-
patient consultations [5]. Previous studies have also
found high incidences of invasive pneumococcal dis-
ease (IPD) among Inuit, such as meningitis [21].
We found a national coverage rate above the WHO-
recommended 90% at 3 months but gradually dropping
at 5 months and 12 months. Kujataa and Qeqqa had
a coverage above 90% for all three vaccinations and
Disko dropped below to 89.3% only at 5 months.
Sermersooq had the lowest coverage rate, dropping
as low as 74.6% at 12 months.
Measles, Mumps and Rubella
As measles is a highly infectious disease, WHO recom-
mends a national coverage rate of at least 95% for two
doses of measles-containing vaccine [22].
The coverage rates found in this study are not only
below the WHO-goal but also the estimated world cover-
age of 87% for the first dose and 67% for the second.
Comparing the data from this study with data from WHO
from 2017, Greenland has a coverage rate comparable to
that of India, Iraq, Syria and several sub-Saharan African
countries [23,24].
The two regions with the lowest coverage rates are
by far Sermersooq with 56.8% and 40.9% coverages for
the two vaccinations and Qeqqa with a drop from
85.3% to 49.6% from the first to the second vaccination.
There have been no known cases of measles in
Greenland but being closely connected to Denmark
by air-traffic, there is a risk of measles spreading from
the rest of Europe to Greenland. Denmark has had 15
cases of measles per 30 July 2019, almost a double of
the number of cases in 2018 [25] and are also below the
WHO-recommended coverage rate (94% for the first
vaccination and 89% for the second) [26]. It seems
essential that improvements in the coverage of the
MMR-vaccine become a focus point.
Human Papillomavirus
With an incidence of approximately nine cases per year
per 100,000 inhabitants [27], Greenland has a high inci-
dence of cervical cancer and a high mortality rate of the
disease when compared to the rest of Europe [28].
Greenland has been following the screening pro-
gramme for cervical cancer since 1998, but a study
from 2016 found low screening coverage rates from
1998 to 2011, the highest being 54% in 2011 [29]. As
HPV often is the cause of cervical cancer, this makes
a high coverage of the vaccination against HPV
essential.
Along with Denmark, Greenland was among the first
Nordic countries to introduce the HPV-vaccination in
2009 [30], but the coverage rate of the vaccination in
Greenland has been unknown until now.
We found high national coverage rates of HPV-
vaccinations, however with regional differences. The
national coverage rate in Greenland is higher than the
current nation coverage rate in Denmark (73% for the
first vaccination and 52% for the second) [26] and
comparable to the coverage in other European coun-
tries, where the percentage of girls who receive the
final dose of the vaccination ranges between 14.1%
and 85.9% [31].
Improving vaccination coverage in Greenland
A focused effort is needed to improve the vaccination
coverage rates in Greenland. As Greenland is a country
with a challenging infrastructure and great differences
between the healthcare offered in towns and settle-
ments, multifaceted approaches will be needed, each
tailored to the place they are to be implemented.
In this study, we found clear differences in coverage
rate between the regions regarding certain vaccines
and that Sermersooq, which holds the main hospital
of the country and the country’s largest healthcare-
clinic, often had the lowest coverage rate. We also
found that the coverage rates were highest among
the newborn and then, with a few regional exceptions,
dropping until the HBV-vaccination series started in
school at age 12 years. This could indicate that the
coverage is higher when the family has close contact
with either the healthcare-system or a school which can
provide education and reminders of the CVP.
Education and reminder-systems have proven effec-
tive in other countries. In a study from 2017 concerning
the uptake of HPV-vaccinations among American Indian
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adolescents, Jacobs-Wingo et al. found several barriers
to the vaccination, the top five being lack of patient
awareness about benefits, missing vaccination data,
clinic access issues, vaccine safety concerns and parent
beliefs that HPV-vaccination increases sexual activity.
Researchers found that clinics expanding their remin-
der-systems, educating the staff and initiating or
expanding patient-education and possibilities for hav-
ing the vaccinations outside the clinic, improved the
initiation of the HPV-vaccines from 47% to 71% and
completion from 20% to 42% [32].
Following the annual assessment of the coverage rate
of the children vaccination programme in Denmark in
2018, Statens Serum Institut conducted interviews with
the regions having the highest coverage rates of the
MMR-vaccination. These interviews showed that also in
Denmark, regions focusing on education of parents, col-
laboration between general practitioners and nurses con-
ducting home-visits among new parents and expansion
of reminder-systems have the highest coverage rate [26].
One SMS reminder improved the vaccination rate
among the subgroup in Nuuk missing the MMR-1 vaccine,
in particular among children that were missing only this
vaccine. Thus, SMS-reminders may be one way to improve
vaccination rates. However, additional alternatives have to
be considered to reach acceptable vaccination rates
including repeated SMS-reminders, direct telephone con-
tact with parents and follow-up on vaccination status
among all children upon contact to the healthcare-
system, at school entry and in day care intuitions.
Conclusion
We found an overall national coverage that is close to the
WHO-recommendations and especially high among the
newborn. However, great regional differences were
observed. It is vital that the coverage rate is monitored
closely in the future and a catch-up strategy for the children
missing one or more vaccinations should be introduced
along with other initiatives to improve coverage rate.
Strengths and limitations
This is the first study based on individual registration of
vaccinations in the EMR focusing on the coverage rate
of the CVP among children in all of Greenland and
including all health regions. The coverage rates
reported in this study should be interpreted as mini-
mum rates, as the design of the cohorts may make the
coverage rates appear lower than they actually are.
Among the youngest, children born prematurely may
receive the BCG- and HBV-vaccinations with some delay
due to their immature immune system at birth. Among
the older children, the vaccinations given in school may
have been given later than assumed in this study, if the
child has entered school at an older age than expected.
The organisation of vaccination-schedules may differ
among regions and especially the coverage rates of the
vaccination against DTPHiB at age 5 to 6 years,
the second against HPV and the third against HBV at
age 12 years, may reflect planned delays in the vaccine
programme rather than lack of adherence. Thus, these
vaccination rates must be taken with clear reservations.
Children who have moved to Greenland from other
countries may have been given the vaccinations before
departing their home-country and may therefore
appear in the EMR as not having received the vaccina-
tion, even if this is not the case. The analysis of the
subgroup in Nuuk indicated that this underestimation
may account for 3% to 4%.
The subgroup-analysis of the effect of SMS-
reminders among children in Nuuk was conducted
without a control group. Thus, these results must not
be considered conclusive until they have been con-
firmed in more expansive studies.
Finally, there is a small possibility that some vaccinations
could have been administered, but not registered in the
EMR. However, when doing the data-validation of 500
children, we found no disagreements between the
extracted data and the notes written by the healthcare
staff in the EMR.
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